These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19515564)

  • 21. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines.
    Pratt JK; Donner P; McDaniel KF; Maring CJ; Kati WM; Mo H; Middleton T; Liu Y; Ng T; Xie Q; Zhang R; Montgomery D; Molla A; Kempf DJ; Kohlbrenner W
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1577-82. PubMed ID: 15745800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase.
    Ellis DA; Blazel JK; Webber SE; Tran CV; Dragovich PS; Sun Z; Ruebsam F; McGuire HM; Xiang AX; Zhao J; Li LS; Zhou Y; Han Q; Kissinger CR; Showalter RE; Lardy M; Shah AM; Tsan M; Patel R; LeBrun LA; Kamran R; Bartkowski DM; Nolan TG; Norris DA; Sergeeva MV; Kirkovsky L
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4628-32. PubMed ID: 18662878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Ding Y; Girardet JL; Smith KL; Larson G; Prigaro B; Lai VC; Zhong W; Wu JZ
    Bioorg Med Chem Lett; 2005 Feb; 15(3):675-8. PubMed ID: 15664835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
    Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors.
    Ikegashira K; Oka T; Hirashima S; Noji S; Yamanaka H; Hara Y; Adachi T; Tsuruha J; Doi S; Hase Y; Noguchi T; Ando I; Ogura N; Ikeda S; Hashimoto H
    J Med Chem; 2006 Nov; 49(24):6950-3. PubMed ID: 17125247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Fitch DM; Evans KA; Chai D; Duffy KJ
    Org Lett; 2005 Nov; 7(24):5521-4. PubMed ID: 16288546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model.
    Chen CM; He Y; Lu L; Lim HB; Tripathi RL; Middleton T; Hernandez LE; Beno DW; Long MA; Kati WM; Bosse TD; Larson DP; Wagner R; Lanford RE; Kohlbrenner WE; Kempf DJ; Pilot-Matias TJ; Molla A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4290-6. PubMed ID: 17908950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Hydrazinopurine 2'-methyl ribonucleosides and their 5'-monophosphate prodrugs as potent hepatitis C virus inhibitors.
    Gunic E; Chow S; Rong F; Ramasamy K; Raney A; Li DY; Huang J; Hamatake RK; Hong Z; Girardet JL
    Bioorg Med Chem Lett; 2007 May; 17(9):2456-8. PubMed ID: 17331718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyrones.
    Li H; Linton A; Tatlock J; Gonzalez J; Borchardt A; Abreo M; Jewell T; Patel L; Drowns M; Ludlum S; Goble M; Yang M; Blazel J; Rahavendran R; Skor H; Shi S; Lewis C; Fuhrman S
    J Med Chem; 2007 Aug; 50(17):3969-72. PubMed ID: 17658778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
    Randolph JT; Flentge CA; Huang PP; Hutchinson DK; Klein LL; Lim HB; Mondal R; Reisch T; Montgomery DA; Jiang WW; Masse SV; Hernandez LE; Henry RF; Liu Y; Koev G; Kati WM; Stewart KD; Beno DW; Molla A; Kempf DJ
    J Med Chem; 2009 May; 52(10):3174-83. PubMed ID: 19402666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase.
    Habermann J; Capitò E; Ferreira Mdel R; Koch U; Narjes F
    Bioorg Med Chem Lett; 2009 Feb; 19(3):633-8. PubMed ID: 19109015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay.
    Stammers TA; Coulombe R; Duplessis M; Fazal G; Gagnon A; Garneau M; Goulet S; Jakalian A; LaPlante S; Rancourt J; Thavonekham B; Wernic D; Kukolj G; Beaulieu PL
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6879-85. PubMed ID: 24176401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Çakir G; Küçükgüzel İ; Guhamazumder R; Tatar E; Manvar D; Basu A; Patel BA; Zia J; Talele TT; Kaushik-Basu N
    Arch Pharm (Weinheim); 2015 Jan; 348(1):10-22. PubMed ID: 25449674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase.
    Chen KX; Vibulbhan B; Yang W; Sannigrahi M; Velazquez F; Chan TY; Venkatraman S; Anilkumar GN; Zeng Q; Bennet F; Jiang Y; Lesburg CA; Duca J; Pinto P; Gavalas S; Huang Y; Wu W; Selyutin O; Agrawal S; Feld B; Huang HC; Li C; Cheng KC; Shih NY; Kozlowski JA; Rosenblum SB; Njoroge FG
    J Med Chem; 2012 Jan; 55(2):754-65. PubMed ID: 22148957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.
    Zhou Y; Webber SE; Murphy DE; Li LS; Dragovich PS; Tran CV; Sun Z; Ruebsam F; Shah AM; Tsan M; Showalter RE; Patel R; Li B; Zhao Q; Han Q; Hermann T; Kissinger CR; Lebrun L; Sergeeva MV; Kirkovsky L
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1413-8. PubMed ID: 18242088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
    Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
    Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease.
    Slater MJ; Amphlett EM; Andrews DM; Bamborough P; Carey SJ; Johnson MR; Jones PS; Mills G; Parry NR; Somers DO; Stewart AJ; Skarzynski T
    Org Lett; 2003 Nov; 5(24):4627-30. PubMed ID: 14627400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
    Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides.
    Krueger AC; Madigan DL; Jiang WW; Kati WM; Liu D; Liu Y; Maring CJ; Masse S; McDaniel KF; Middleton T; Mo H; Molla A; Montgomery D; Pratt JK; Rockway TW; Zhang R; Kempf DJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3367-70. PubMed ID: 16650764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues.
    Kim J; Kim KS; Lee HS; Park KS; Park SY; Kang SY; Lee SJ; Park HS; Kim DE; Chong Y
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4661-5. PubMed ID: 18644717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.